These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 12374902)

  • 21. Calcium sensitizer agents: a new class of inotropic agents in the treatment of decompensated heart failure.
    Perrone SV; Kaplinsky EJ
    Int J Cardiol; 2005 Sep; 103(3):248-55. PubMed ID: 16098385
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Calcium sensitization as new principle of inotropic therapy in end-stage heart failure?
    Zimmermann N; Boknik P; Gams E; Herzig JW; Neumann J; Scholz H
    Eur J Cardiothorac Surg; 1998 Jul; 14(1):70-5. PubMed ID: 9726618
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Levosimendan].
    Michels G; Herzig S; Hoppe UC
    Dtsch Med Wochenschr; 2005 Oct; 130(43):2444-6. PubMed ID: 16240243
    [No Abstract]   [Full Text] [Related]  

  • 24. Use of pimobendan in the management of heart failure.
    Fuentes VL
    Vet Clin North Am Small Anim Pract; 2004 Sep; 34(5):1145-55. PubMed ID: 15325474
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Inotrope therapy in acute heart failure: a critical review of clinical and scientific evidence for levosimendan in the context of traditional treatment].
    Ambrosio G; Di Lenarda A; Fedele F; Gabrielli D; Metra M; Oliva F; Perna G; Senni M; De Maria R
    G Ital Cardiol (Rome); 2009 Jul; 10(7):422-33. PubMed ID: 19761100
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel approach to the development of positive inotropic agents for chronic heart failure.
    Packer M
    J Cardiovasc Pharmacol; 1995; 26 Suppl 1():S52-6. PubMed ID: 8907131
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The use of inotropic agents in acute and chronic congestive heart failure.
    Sanders MR; Kostis JB; Frishman WH
    Med Clin North Am; 1989 Mar; 73(2):283-314. PubMed ID: 2645478
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hemodynamic, neurohumoral, and myocardial energetic effects of pimobendan, a novel calcium-sensitizing compound, in patients with mild to moderate heart failure.
    Remme WJ; Kruijssen DA; van Hoogenhuyze DC; Krauss XH; Bartels GL; Storm CJ; de Leeuw PW
    J Cardiovasc Pharmacol; 1994 Nov; 24(5):730-9. PubMed ID: 7532750
    [TBL] [Abstract][Full Text] [Related]  

  • 29. EMD 53998 acts as Ca(2+)-sensitizer and phosphodiesterase III-inhibitor in human myocardium.
    Uhlmann R; Schwinger RH; Lues I; Erdmann E
    Basic Res Cardiol; 1995; 90(5):365-71. PubMed ID: 8585857
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Calcium sensitisers: mechanisms of action and potential usefulness as inotropes.
    Lee JA; Allen DG
    Cardiovasc Res; 1997 Oct; 36(1):10-20. PubMed ID: 9415267
    [No Abstract]   [Full Text] [Related]  

  • 31. Novel pharmacological treatments for heart failure.
    Tang WH; Francis GS
    Expert Opin Investig Drugs; 2003 Nov; 12(11):1791-801. PubMed ID: 14585055
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Levosimendan: beyond its simple inotropic effect in heart failure.
    Antoniades C; Tousoulis D; Koumallos N; Marinou K; Stefanadis C
    Pharmacol Ther; 2007 May; 114(2):184-97. PubMed ID: 17363065
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Calcium sensitizer agents in heart failure therapy].
    Iwama Y; Takagi A
    Nihon Rinsho; 2007 May; 65 Suppl 5():61-5. PubMed ID: 17571366
    [No Abstract]   [Full Text] [Related]  

  • 34. Cardiotonic agents. 1. 4,5-Dihydro-6-[4-(1H-imidazol-1-yl)phenyl]-3 (2H)-pyridazinones: novel positive inotropic agents for the treatment of congestive heart failure.
    Bristol JA; Sircar I; Moos WH; Evans DB; Weishaar RE
    J Med Chem; 1984 Sep; 27(9):1099-101. PubMed ID: 6471063
    [No Abstract]   [Full Text] [Related]  

  • 35. The use of cytokine inhibitors. A new therapeutic insight into heart failure.
    Matsumori A
    Int J Cardiol; 1997 Dec; 62 Suppl 1():S3-12. PubMed ID: 9464576
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Vasoactive and inotropic drugs in acute heart failure].
    Ruiz-Laiglesia FJ; Camafort-Babkowski M
    Med Clin (Barc); 2014 Mar; 142 Suppl 1():49-54. PubMed ID: 24930084
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of chronic heart failure with positive inotropic agents].
    Lechat P
    Therapie; 1989; 44(6):437-45. PubMed ID: 2576155
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Do positive inotropic agents adversely affect the survival of patients with chronic congestive heart failure? II. Protagonist's viewpoint.
    Packer M
    J Am Coll Cardiol; 1988 Aug; 12(2):562-6. PubMed ID: 3392349
    [No Abstract]   [Full Text] [Related]  

  • 39. [New inotropic agents in the treatment of congestive heart failure].
    Freitas M
    Rev Port Cardiol; 1993 Nov; 12 Suppl 4():19-28, 7-8. PubMed ID: 7904458
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment of heart failure patients with inotropic drugs: beyond traditional agents].
    Metra M; Lombardi C; Carubelli V; Bettari L; Bugatti S; Danesi R; Lazzarini V; Monti A; Villa C; Dei Cas L
    G Ital Cardiol (Rome); 2010 Oct; 11(10 Suppl 1):143S-148S. PubMed ID: 21416846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.